Literature DB >> 15773284

Celecoxib-cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage.

M S Nagarsenker1, M S Joshi.   

Abstract

Solid dispersions of Celecoxib were prepared with hydroxypropyl beta cyclodextrin by various methods such as physical mixture, cogrinding, kneading, and coevaporation. The dispersions were characterized by differential scanning calorimetry (DSC), X-ray diffraction patterns, infrared spectroscopy, and nuclear magnetic resonance studies. The DSC thermograms of the dispersions indicated potential of heat-induced interaction between Celecoxib and cyclodextrin that could influence in vitro drug dissolution. The dispersions exhibited faster rates of dissolution compared to that of Celecoxib. The kneaded dispersion with the fastest in vitro dissolution rate when compressed into tablets showed a better release profile compared to the tablets of pure Celecoxib. In vivo studies revealed that the kneaded dispersion provided for quicker response and was more effective in inhibiting rat paw edema as compared to Celecoxib alone, thus confirming the advantage of improved pharmacological activity of Celecoxib when administered as a solid dispersion with cyclodextrin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773284     DOI: 10.1081/ddc-200047795

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

2.  Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.

Authors:  Angela Lopedota; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Rosa Maria Iacobazzi; Mara Perrone; Elisabetta Fanizza; Maria Mastrodonato; Donatella Mentino; Antonio Lopalco; Nicoletta Depalo; Massimo Franco
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

Review 3.  Preclinical formulations: insight, strategies, and practical considerations.

Authors:  Sanket M Shah; Ankitkumar S Jain; Ritu Kaushik; Mangal S Nagarsenker; Maneesh J Nerurkar
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

4.  Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.

Authors:  Anju Malkani; Abhijit A Date; Darshana Hegde
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

5.  Experimental Design to Predict Process Variables in the Microcrystals of Celecoxib for Dissolution Rate Enhancement Using Response Surface Methodology.

Authors:  Mitra Jelvehgari; Hadi Valizadeh; Seyed Hassan Montazam; Sanam Abbaszadeh
Journal:  Adv Pharm Bull       Date:  2015-06-01

6.  Aripiprazole-cyclodextrin binary systems for dissolution enhancement: effect of preparation technique, cyclodextrin type and molar ratio.

Authors:  Shaimaa M Badr-Eldin; Tarek A Ahmed; Hatem R Ismail
Journal:  Iran J Basic Med Sci       Date:  2013-12       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.